Free Republic
Browse · Search
News/Activism
Topics · Post Article

Skip to comments.

Common asthma treatment reduces need for hospitalization in COVID-19 patients, study suggest (Budesonide)
Medical Xpress.com ^ | February 10, 2021

Posted on 02/15/2021 9:51:11 AM PST by KeyLargo

Medications

February 10, 2021

Common asthma treatment reduces need for hospitalization in COVID-19 patients, study suggests

by University of Oxford

Early treatment with a medication commonly used to treat asthma appears to significantly reduce the need for urgent care and hospitalization in people with COVID-19, researchers at the University of Oxford have found.

The STOIC study found that inhaled budesonide given to patients with COVID-19 within seven days of the onset of symptoms also reduced recovery time. Budesonide is a corticosteroid used in the long-term management of asthma and chronic obstructive pulmonary disease (COPD).

Findings from the phase 2 randomized study, which was supported by the NIHR Oxford Biomedical Research Centre (BRC), were published on the medRxiv pre-print server.

The findings from 146 people—of whom half took 800 micrograms of the medication twice a day and half were on usual care—suggests that inhaled budesonide reduced the relative risk of requiring urgent care or hospitalization by 90% in the 28-day study period. Participants allocated the budesonide inhaler also had a quicker resolution of fever, symptoms and fewer persistent symptoms after 28 days....

(Excerpt) Read more at medicalxpress.com ...


TOPICS: Culture/Society; News/Current Events; Technical; United Kingdom
KEYWORDS: budesonide; chinavirustreatment; covid19; hospital; treatment

This morning, on AM radio, an MD was describing one type of treatment for COVID19 that many hospitals refuse to use, rather than use the proven medication.

1 posted on 02/15/2021 9:51:11 AM PST by KeyLargo
[ Post Reply | Private Reply | View Replies]

To: KeyLargo

Budesonide is an inhaled corticosteroid that is currently being studied for its efficacy with COVID-19. It is a common, safe prescription therapy that is FDA-approved for breathing issues.

***This website is only informational and has no ties to any drug company or physicians. And no one involved in this website has financial ties to any of the suggested therapies. We are merely patient advocates, trying to save lives and fight medical censorship.**

https://budesonideworks.com/


2 posted on 02/15/2021 9:53:46 AM PST by KeyLargo
[ Post Reply | Private Reply | To 1 | View Replies]

To: KeyLargo

I got a script for the vials you put in a nebulizer. The cost is crazy. Over $300 bucks without insurance. With my insurance it was $30. I dont even know how long they were suppose to last. I know it is less than 30 days


3 posted on 02/15/2021 9:54:40 AM PST by RummyChick (To President Trump: https://freerepublic.com/focus/f-chat/3923111/posts)
[ Post Reply | Private Reply | To 1 | View Replies]

To: RummyChick

UK

GPs could offer common asthma drug as early Covid-19 intervention

asthma drug

Helen Quinn
15 February 2021

A common asthma drug, Budesonide, which could be given by GP surgeries as an early community intervention, has been found to reduce Covid-19 symptoms.

In a small trial at the University of Oxford, the steroid inhaler was given seven days after the onset of Covid-19 symptoms and appeared to significantly reduce the need for critical care.

The researchers also reported persistent symptoms, seen after 28 days, were reduced with the asthma drug.

The study, which has yet to be peer-reviewed, involved 146 people who had tested positive for Covid-19, half of whom were given 800 mg of Budesonide twice a day and the other half received the usual care.

The researchers found that using the steroid inhaler reduced the relative risk of needing critical care by 90% over the study period. They also found that there was a quicker resolution of fever and less persistent symptoms after 28 days.

The study was published on the medRxiv pre-print server, but the researchers were optimistic that the common medication could help.

Professor Mona Bafadhel from the University of Oxford, who led the trial, said: ‘There have been important breakthroughs in hospitalised Covid-19 patients, but equally important is treating early disease to prevent clinical deterioration and the need for urgent care and hospitalisation.’

She added: ‘I am heartened that a relatively safe, widely available and well-studied medicine such as an inhaled steroid could have an impact on the pressures we are experiencing during the pandemic.’

As the effects of long Covid-19 become more visible, GPs have been asked to manage the long-term health issues associated with the virus.

https://www.pulsetoday.co.uk/news/clinical-areas/respiratory/gps-could-offer-common-asthma-drug-as-early-covid-19-intervention/


4 posted on 02/15/2021 10:01:45 AM PST by KeyLargo
[ Post Reply | Private Reply | To 3 | View Replies]

To: RummyChick

btw, if you get a script for the vials you also have to have a nebulizer. The pharmacy required a script. What is the sense in that when you can get one off Amazon.

People bash Amazon all the time like it is a sport but they sure have helped me out many times.

btw, their pharmacy will fill Ivermectin and HQC scripts

I was reading a pharmacist thread on reddit. A lot of pharmacists have flat out refused to fill valid scripts. This happened to me with HQC. I had to shop around to get it. I had to shop around for Ivermectin because so many places didnt have it.


5 posted on 02/15/2021 10:06:24 AM PST by RummyChick (To President Trump: https://freerepublic.com/focus/f-chat/3923111/posts)
[ Post Reply | Private Reply | To 3 | View Replies]

To: KeyLargo

I think that when this panic over Chirona is over we may find that it can be cured by taking aspirin.

How dangerous ca a virus be when there are so many cures? Sounds like a cold to me.


6 posted on 02/15/2021 10:18:36 AM PST by JayAr36 (My disgust with government is complete.)
[ Post Reply | Private Reply | To 4 | View Replies]

To: JayAr36

7 posted on 02/15/2021 10:54:37 AM PST by KeyLargo
[ Post Reply | Private Reply | To 6 | View Replies]

To: KeyLargo

Will covid 19 be around in 2119?

We could have a centennial celebration.


8 posted on 02/15/2021 11:38:28 AM PST by Pollard (Bunch of curmudgeons)
[ Post Reply | Private Reply | To 1 | View Replies]

To: KeyLargo

Interesting. Small study but great results. Hope it can be replicated.
Another recent study found no benefit in asthma patients.

• A meta-analysis of four published articles including 8155 patients evaluated the impact of inhaled corticosteroids (ICS) and the potential relationship between ICS use and prognosis in patients with asthma and COVID-19 showed no significant difference in case fatality in asthmatic patients in the ICS use and non-ICS use groups (J Asthma 2021 Jan 18;EPub Ahead of Print).


9 posted on 02/15/2021 12:39:03 PM PST by consult
[ Post Reply | Private Reply | To 1 | View Replies]

To: KeyLargo

FYI, Symicort is budesonide 160 mcg / formoterol fumarate dihydrate 4.5 mcg or budesonide 80 mcg / formoterol fumarate dihydrate 4.5 mcg


10 posted on 02/15/2021 2:38:17 PM PST by egfowler3 (American Trump Voter (AKA: Deplorable, Clinger, Christian Infidel & American!))
[ Post Reply | Private Reply | To 1 | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
News/Activism
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson